ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Oklahoma » Internal Medicine

Top Internal Medicine Prescribers in Oklahoma

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ARVID LADE M.D.

Internal Medicine

37,251

$2.22M

1036
944 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $64

ADEL MALATI M.D.

Internal Medicine

35,763

$2.04M

769
509 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

28%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $64

RODGER SPILLARS M.D.

Internal Medicine

27,110

$1.83M

551
435 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

34%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$67
Average prescription price

Avg: $64

STEVEN WISEMAN M.D.

Internal Medicine

26,632

$1.31M

1007
841 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

20%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $64

MELINDA ALLEN DO

Internal Medicine

24,680

$1.33M

798
586 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

25%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $64

WELLIE ADLAON M.D.

Internal Medicine

23,944

$2.36M

554
195 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

26%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 25%

$99
Average prescription price

Avg: $64

DEEPAK JAISWAL M.D.

Internal Medicine

23,495

$1.43M

737
562 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

25%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $64

BRUCE DENNIS MD

Internal Medicine

22,160

$1.54M

537
345 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$69
Average prescription price

Avg: $64

PATRICK GRAY M.D.

Internal Medicine

21,962

$1.19M

798
732 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $64

DON HESS M.D.

Internal Medicine

20,796

$1.18M

976
885 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

19%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $64

ERIC WEST MD

Internal Medicine

20,560

$1.18M

657
431 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

23%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $64

JOHN MOORE D.O.

Internal Medicine

20,149

$1M

579
513 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

23%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $64

GEO PHILIPS CHACKO MD

Internal Medicine

20,140

$1.29M

651
429 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

37%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $64

JON COX M.D.

Internal Medicine

19,830

$900K

1038
871 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $64

THOMAS MERRILL M.D.

Internal Medicine

19,562

$1.17M

701
656 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $64

SIDNEY WILLIAMS M.D.

Internal Medicine

19,535

$1.69M

467
194 are 65+

56%
patients receiving schedule two controlled substances

Avg: 5%

49%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$86
Average prescription price

Avg: $64

PAUL HOBBS MD

Internal Medicine

19,339

$1.28M

911
740 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

28%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$66
Average prescription price

Avg: $64

RANILO VASQUEZ M.D.

Internal Medicine

19,269

$1.16M

837
743 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $64

MICHAEL MAXWELL M.D.

Internal Medicine

18,927

$958K

796
728 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $64

ROBERT HIGHTOWER DO

Internal Medicine

17,416

$936K

497
343 are 65+

17%
patients receiving schedule two controlled substances

Avg: 5%

33%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $64

DAVID LESTER M.D.

Internal Medicine

17,385

$970K

740
585 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

28%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $64

ROBERT LOVE MD

Internal Medicine

17,237

$1.53M

521
385 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

30%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 25%

$89
Average prescription price

Avg: $64

SANGEETA KHETPAL MD

Internal Medicine

17,206

$1.4M

936
557 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

35%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$82
Average prescription price

Avg: $64

MERLE DAVIS M.D.

Internal Medicine

16,643

$896K

599
538 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

17%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $64

TODD KREHBIEL M.D.

Internal Medicine

16,640

$1.42M

456
315 are 65+

16%
patients receiving schedule two controlled substances

Avg: 5%

37%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 25%

$85
Average prescription price

Avg: $64

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank